Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Jan 1, 2021·

Angel YS Wong

,

Brian MacKenna

,

Caroline E Morton

,

Anna Schultze

,

Alex J Walker

,

Krishnan Bhaskaran

,

Jeremy P Brown

,

Christopher T Rentsch

,

Elizabeth Williamson

,

Henry Drysdale

,

Others

· 0 min read

Type

Journal article

Publication

Annals of the rheumatic diseases

Last updated on Jan 1, 2021

← Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study Jan 1, 2021

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform Jan 1, 2020 →